Benjamin L Maughan
@maughanonc
Followers
1K
Following
2K
Media
67
Statuses
1K
I am a physician specializing in the treatment of genitourinary cancers. I am passionate for improving cancer therapy through research.
Salt Lake City, UT
Joined February 2017
True but with such a high relapse rate the bigger problem presently is relatively low cure rates. This powerful prognostic tool can help with next generation studies to really focus intensification on the at risk patients. Will really help drive innovation faster.
This @NatRevClinOncol @scocmem shows in the adjuvant UC setting ctDNA -ves have landmark OS >95%, while the ctDNA +ves benefit from IO (TOMBOLA,IM011,CM274).The problem is these adjuvant studies tell us when to start adjuvant IO & not when to stop Perioperative IO(NIAGARA KN905)
0
0
8
Speaking of gratitude 🦃 If you catch the break in my voice about half way through this interview while discussing the progress in chromophobe RCC in the past 5 years, know that’s the immense gratitude I have for the work and progress being made in chRCC seeping through. In
1/3 Targeting FSP1 in Chromophobe RCC. We’re excited to share a new video featuring Dr. @SamerSalem18, who recently completed his postdoc in Dr. @LisaHenske’s lab at Brigham and Women's Hospital discussing FSP1. Watch the full discussion:
0
3
10
No shoes! 🤣 Happy thanksgiving. Love seeing the pics in series.
0
0
3
We are grateful for YOU! Our #KidneyCancer community's generosity supports critical patient resources and fuels life-changing research. Thank you for the gift of hope that continues to drive us towards a cure - we know we're closer than ever. 🧡 #HappyThanksgiving!
0
1
9
I am grateful for the mentors in my life. @neerajaiims for so many things including convincing me to do GU instead of leukemia. @EAntonarakis taught me clinical oncology and clinical biomarker research. @montypal for guiding me through the cooperative group mechanism. ❤️ GU peeps
4
8
70
In the spirit of Thanksgiving, I’m thankful for my recent appointment as Chair of GU Disease Group @MayoClinic Enterprise. Very much looking forward to further collaboration with multi-D experts and friends across the destination sites @MayoCancerCare
https://t.co/J1ZDhhq0Cl
39
18
125
You are the best candidate for this position. You have my vote and those of many others I hope!
Voting for the ASCO election is now open! I am honored to be running as one of the candidates for the @ASCO Nominating Committee seat. Visit https://t.co/4riSVk7AQy to learn more about the candidates and place your vote! Thank you!!
0
1
5
Voting for the ASCO election is now open! I am honored to be running as one of the candidates for the @ASCO Nominating Committee seat. Visit https://t.co/4riSVk7AQy to learn more about the candidates and place your vote! Thank you!!
19
100
235
Grateful for @eric_facs @OSUCCC_James — KCA Medical Steering Committee member and Mentorship Academy co-chair — for offering his insights on day one of #IKCSNA25! 🧡🤝
0
8
22
The #kidneycancer godfather #NizarTannir receives the inaugural mentorship excellence award @KidneyCancer #IKCSNA25 - sharing the award w his mentees and reminding us to pass it forward, give the spotlight, #unstoppabletogether
0
11
33
🎉 Congratulations @AChakrabortyPhD @CCLRI on receiving the KCA's Christopher G. Wood Rising Star Award, recognizing promising scientists pursuing excellence in #kidneycancer in honor of our late Chair and friend, Dr. Christopher G. Wood. #IKCSNA25
3
9
47
Tour de force review of refractory non-clear cell RCC by @MVossMD of @MSKCancerCenter at #IKCSNA25 @KidneyCancer. Many important ongoing studies as below. Promising novel targets / mechanisms: ENPP3xCD3 bispecific, NF2, PRMT5 for CDKN2A/MTAP loss. Still huge unmet need
0
8
14
Dena Battle @RCCadvocate @kcCURE with poignant discussion of perceptions of cure in #kidneycancer. There’s a social contract and hope loaded in this word CURE — should we consider remission or other verbiage? @KidneyCancer #IKCSNA25
0
12
27
@MdArpita @UCSFCancer w broad overview on refractory #kidneycancer treatments — HIF inhibitors, CA-IX targeting radioligands, & post IO sequencing. Challenged we face all the time in clinic — each life extending therapy will help our patients live longer. @KidneyCancer #IKCSNA25
1
5
16
She’s so big!!! I remember seeing her at all the ASCO meeting as a teencie little baby ❤️
Always great hanging out with the Bergerot Family! Including Ann joining in the photo fun!
0
0
4
Quite frankly — it’s the best video! Surely team America wins with this quality entry!
@Uromigos @OncoAlert Yes we are losing quite badly - but I hope you will enjoy & like the above video! All my amateur video skills put to the test …
0
1
5
@Uromigos @OncoAlert Yes we are losing quite badly - but I hope you will enjoy & like the above video! All my amateur video skills put to the test …
1
2
6
The unopened box this mug came in has been sitting on my counter for over 9 months. It was the last thing a friend sent before she passed and I couldn’t bring myself to open it, so I’ve just been moving it around the kitchen all year. Finally opened it today and this beautiful
1
2
9
The bar is high! In order to prove the benefit of IO rechallenge, prospective evidence is needed after key efforts in #kidneycancer. Great summary from @DrKarineTawagi. @uromigos @brian_rini @tompowles1
Is there any role for #immunotherapy rechallenge in #bladdercancer? @DrKarineTawagi discusses this in the latest #UromigosShorts video. @OncoAlert
0
8
15
This is amazing! Sometimes I feel over dressed wearing my suit on the plane but this is a good reminder that style doesn’t compromise 😎
Ok-I may be a bit overdressed for the airport but very excited to be heading to #napa for the @auawest meeting for a week filled with outstanding presentations, posters, courses, world-class speakers and fun networking with friends and colleagues in a beautiful setting.
0
0
2